Positron Corporation (POSC)
Stock analysis · OTC · Healthcare · Medical - Devices
Positron Corporation (POSC) is a publicly traded company in the Healthcare sector. Latest price: $1.70. Market cap $55.84M. Trailing PE -5.48. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Proprietary Signals
About Positron Corporation
Positron Corporation is a healthcare firm specializing in nuclear medicine, with a core emphasis on cardiac Positron Emission Tomography (PET) imaging services throughout the United States. The company empowers healthcare providers by offering its proprietary Attrius PET scanner, comprehensive clinical and technical support, and flexible financing solutions. These integrated offerings enable medical professionals to precisely diagnose heart conditions, enhance patient health outcomes, and deliver medical care with greater cost-efficiency. Positron Corporation was founded in 1983 and operates from its headquarters in Niagara Falls, New York.
Valuation
| P/E (TTM) | -5.48× |
|---|---|
| P/S (TTM) | 125.53× |
| P/B | -84.50× |
| PEG | 0.05× |
| P/FCF (TTM) | -12.94× |
| EV / EBITDA | -5.70× |
| EV / Sales | 128.34× |
| Earnings Yield | -18.17% |
| Free Cash Flow Yield | -7.73% |
Fundamentals
| Enterprise Value | $57.09M |
|---|---|
| Revenue (TTM) | $444.82K |
| Net Income (TTM) | -$10.14M |
| Free Cash Flow (TTM) | -$4.21M |
| Net Debt | $1.25M |
| Working Capital | -$1.15M |
| Gross Margin | -531.90% |
| Operating Margin | -2264.74% |
| Net Margin | -2280.56% |
| Return on Equity | -1759.59% |
| Return on Invested Capital | -1063.98% |
Peers
Recent News
Related
Browse more tickers: sitemap